|
|
|
| home > ebr > summer 2003 > losing our minds - what the future holds for the treatment of neurodegenerative disorders |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| The words Alzheimer's or Parkinson's can strike terror in anyone's mind, particularly those of us aged over 50. With the average age of the western world's population rising, a disturbing flipside is that an increasing number of those that enter their 60s and beyond are falling victim to neurodegenerative conditions such as Alzheimer's, Parkinson's and stroke. Billions of dollars have been spent on developing novel effective treatments for these conditions with little success. More importantly, treatments that could actually modify the progress of these diseases rather than merely alleviate some of their symptoms, are urgently required. Demand for new and more effective drugs will therefore continue to intensify. Fortunately, there are now signs of light at the end of the tunnel and the near future could see significant progress in the battle to win back our minds. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
PHASE II & IIa Clinical Trials
21-22 February 2012, Lancaster London Hotel, London
Learn how to overcome challenges in adapting the development process to achieve early Proof of Concept at Informa's 13th Annual Phase I & IIa Clinical Trials event.
More info >> |
|
 |
News and Press Releases |
 |
Topa Thermal Packaging introduces innovative pallet shipper
Topa Thermal Packaging has developed an innovative packaging for manufacturers that transport large quantities of temperature-sensitive products by road and air transport, such as vaccines and medicines. The ‘ClimateBox™ half PAG Pallet Shipper’ delivers significant time and cost savings, thanks to an efficient filling system.
More info >> |
|
|
